Two Sigma Advisers LP trimmed its position in Amdocs Limited (NASDAQ:DOX - Free Report) by 16.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 242,200 shares of the technology company's stock after selling 49,300 shares during the quarter. Two Sigma Advisers LP owned about 0.21% of Amdocs worth $21,188,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also modified their holdings of the company. Private Trust Co. NA lifted its stake in shares of Amdocs by 62.9% in the third quarter. Private Trust Co. NA now owns 303 shares of the technology company's stock worth $27,000 after buying an additional 117 shares during the last quarter. Brooklyn Investment Group acquired a new position in Amdocs during the 3rd quarter valued at $28,000. Catalyst Capital Advisors LLC acquired a new position in Amdocs during the 3rd quarter valued at $55,000. GAMMA Investing LLC raised its stake in Amdocs by 115.1% during the 3rd quarter. GAMMA Investing LLC now owns 800 shares of the technology company's stock valued at $70,000 after purchasing an additional 428 shares during the last quarter. Finally, Meeder Asset Management Inc. acquired a new position in Amdocs during the 3rd quarter valued at $77,000. 92.02% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several equities analysts recently commented on the stock. Barclays cut their target price on shares of Amdocs from $113.00 to $111.00 and set an "overweight" rating for the company in a research note on Thursday, November 14th. StockNews.com cut shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research note on Thursday, November 14th. Stifel Nicolaus assumed coverage on shares of Amdocs in a research note on Wednesday, October 2nd. They issued a "buy" rating and a $100.00 price objective for the company. Finally, Oppenheimer increased their price objective on shares of Amdocs from $98.00 to $105.00 and gave the company an "outperform" rating in a research note on Wednesday, November 13th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, Amdocs currently has an average rating of "Moderate Buy" and a consensus target price of $101.20.
Check Out Our Latest Stock Report on Amdocs
Amdocs Stock Down 0.5 %
DOX traded down $0.41 during trading on Friday, reaching $86.64. 779,784 shares of the stock were exchanged, compared to its average volume of 760,323. The stock has a market cap of $10.18 billion, a P/E ratio of 20.43, a price-to-earnings-growth ratio of 1.46 and a beta of 0.72. Amdocs Limited has a twelve month low of $74.41 and a twelve month high of $94.04. The stock's 50 day moving average price is $88.12 and its two-hundred day moving average price is $84.27. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.24 and a current ratio of 1.20.
Amdocs Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a $0.479 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $1.92 annualized dividend and a dividend yield of 2.21%. Amdocs's dividend payout ratio is currently 45.05%.
Amdocs Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
See Also
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
